|
2024
|
Invention
|
De-immunized shiga toxin a subunit effector polypeptides for applications in mammals.
The presen... |
|
|
Invention
|
Mhc class i epitope delivering polypeptides.
The present invention is directed to T-cell epitope... |
|
|
Invention
|
Pd-l1-binding molecules comprising shiga toxin a subunit scaffolds.
Provided herein are PD-L1 bi... |
|
2023
|
Invention
|
Shiga toxin a subunit effector polypeptides, shiga toxin effector scaffolds, and cell-targeting m... |
|
|
Invention
|
Cd38-binding proteins comprising de-immunized shiga toxin a subunit effectors. The instant invent... |
|
|
Invention
|
Ctla-4 binding molecules comprising shiga toxin a subunit scaffolds and uses thereof.
Provided h... |
|
|
Invention
|
Ctla-4 binding molecules comprising shiga toxin a subunit scaffolds and uses thereof. Provided he... |
|
|
Invention
|
Her2-targeting molecules comprising de-immunized, shiga toxin a subunit scaffolds.
Provided here... |
|
2022
|
Invention
|
Cell-targeting molecules comprising de-immunized, shiga toxin a subunit effectors and cd8+ t-cell... |
|
|
Invention
|
De-immunized, shiga toxin a subunit scaffolds and cell-targeting molecules comprising the same.
... |
|
|
Invention
|
Proteins comprising binding regions, shiga toxin a subunit effector regions, and carboxy-terminal... |
|
|
Invention
|
Mhc class i epitope delivering polypeptides. The present invention is directed to T-cell epitope ... |
|
|
Invention
|
Pd-l1 binding proteins comprising shiga toxin a subunit scaffolds and cd8+ t cell antigens.
Prov... |
|
|
Invention
|
Pd-l1 binding proteins comprising shiga toxin a subunit scaffolds and cd8+ t cell antigens. e.ge.... |
|
2021
|
Invention
|
Clinical methods for use of a pd-l1-binding molecule comprising a shiga toxin effector. The prese... |
|
|
Invention
|
Clinical methods for use of a pd-l1-binding molecule comprising a shiga toxin effector. e.g.e.g.e... |
|
|
Invention
|
Cell-targeting molecules comprising shiga toxin a subunit effectors and cd8+ t-cell epitopes.
Th... |
|
|
Invention
|
Clinical methods for use of her2 binding molecules.
Provided herein are methods for treating or ... |
|
|
Invention
|
Clinical methods for use of her2 binding molecules. Provided herein are methods for treating or p... |
|
|
Invention
|
De-immunized shiga toxin a subunit effector polypeptides for applications in mammals. The present... |
|
|
Invention
|
De-immunized, shiga toxin a subunit scaffolds and cell-targeting molecules comprising the same. T... |
|
|
Invention
|
Pd-l1 targeting molecules comprising shiga toxin a subunit scaffolds.
Provided herein are PD-L1 ... |
|
2020
|
Invention
|
Uses of cd20-binding molecules and additional therapeutic agents.
Provided herein are uses of CD... |
|
|
Invention
|
Uses of cd20-binding molecules and additional therapeutic agents. Provided herein are uses of CD2... |
|
|
Invention
|
Her2-targeting molecules comprising de-immunized, shiga toxin a subunit scaffolds. Provided herei... |
|
|
Invention
|
Cell-targeting molecules comprising protease-cleavage resistant, shiga toxin a subunit effector p... |
|
|
Invention
|
Pd-l1 -binding molecules comprising shiga toxin a subunit scaffolds. Provided herein are PD-L1 bi... |
|
|
Invention
|
Pd-l1 binding molecules comprising shiga toxin a subunit scaffolds. e.ge.ge.ge.ge.g., PD-L1 posit... |
|
|
Invention
|
Pd-l1-binding molecules comprising shiga toxin a subunit scaffolds. Provided herein are PD-L1 bin... |
|
|
Invention
|
Proteins comprising modified immunoglobulin variable light chains. The present invention relates ... |
|
2019
|
Invention
|
Pd-l1 binding proteins. The present invention relates to anti-PD-L1 antibodies. Certain anti-PD-L... |
|
|
Invention
|
Cd20-binding immunotoxins for inducing cellular internalization and methods using same.
The pres... |
|
|
Invention
|
Methods of screening, selecting, and identifying cytotoxic recombinant polypeptides based on an i... |
|
|
Invention
|
Multivalent cd20-binding molecules comprising shiga toxin a subunit effector regions and enriched... |
|
|
Invention
|
Her2-targeting molecules comprising de-immunized, shiga toxin a subunit scaffolds. e.g.e.g.e.g.e.... |
|
2018
|
Invention
|
Cell-targeting molecules comprising amino-terminus proximal or amino-terminal, shiga toxin a subu... |
|
|
Invention
|
Cytotoxic proteins comprising cell-targeting binding regions and shiga toxin a subunit regions fo... |
